April 23, 2026 · Form 4 insider transaction
Lehrer-Graiwer Joshua bought 64,000 shares of Fulcrum Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 8 days after the transaction.
This option was granted on April 23, 2026 and is scheduled to vest in equal monthly installments until April 23, 2029, subject to continued service.